Table 3.
Body fat, % | Fat mass, kg | Lean mass, kg | VAT, g | Android fat, kg | Android fat % | Gynoid fat % | A/G | |
---|---|---|---|---|---|---|---|---|
Blood pressure, mmHg | ||||||||
Systolic | −0.03 | 0.15** | 0.33** | 0.40** | 0.25** | 0.14** | −0.15** | 0.33** |
Diastolic | 0.13* | 0.29** | 0.21** | 0.44** | 0.37** | 0.31** | −0.003 | 0.39** |
Pulse pressure | −0.14** | −0.02 | 0.25** | 0.16** | 0.03 | −0.05 | −0.19** | 0.11* |
Biochemistry | ||||||||
TC, mmol/L | 0.19** | 0.17** | −0.11* | 0.25** | 0.23** | 0.23** | 0.13* | 0.20** |
TAG, mmol/L | 0.21** | 0.35** | 0.18** | 0.46** | 0.42** | 0.38** | 0.06 | 0.43** |
HDL-C, mmol/L | −0.02 | −0.23** | −0.35** | −0.35** | −0.29** | −0.20** | 0.11* | −0.34** |
LDL-C, mmol/L | 0.17** | 0.20** | −0.02 | 0.32** | 0.27** | 0.25** | 0.09 | 0.26** |
Non-HDL-C, mmol/L | 0.22** | 0.27** | 0.02 | 0.41** | 0.36** | 0.33** | 0.10 | 0.35** |
TC: HDL ratio | 0.18** | 0.37** | 0.24** | 0.55** | 0.47** | 0.39** | −0.001 | 0.50** |
LDL-C: HDL-C ratio | 0.16** | 0.33** | 0.23** | 0.51** | 0.43** | 0.35** | −0.01 | 0.46** |
NEFA, μmol/L | 0.20** | 0.12* | −0.17** | 0.04 | 0.10* | 0.15** | 0.20** | −0.02 |
Glucose, mmol/L | 0.07 | 0.23** | 0.22** | 0.41** | 0.31** | 0.23** | −0.05 | 0.35** |
Insulin, pmol/L | 0.35** | 0.41** | 0.02 | 0.34** | 0.41** | 0.42** | 0.24** | 0.32** |
HOMA-IR | 0.34** | 0.42** | 0.06 | 0.38** | 0.43** | 0.42** | 0.21** | 0.34** |
CRP, mg/L | 0.36** | 0.41** | 0.001 | 0.29** | 0.39** | 0.41** | 0.27** | 0.27** |
GGT, U/L | −0.09 | 0.11* | 0.35** | 0.37** | 0.22** | 0.11 | −0.22** | 0.36** |
Uric acid, µmol/L | −0.16** | 0.13* | 0.53** | 0.43** | 0.29** | 0.13* | −0.35** | 0.51** |
Adiponectin, µg/mL | 0.18** | 0.02 | −0.25** | −0.14** | −0.05 | 0.02 | 0.25** | −0.21 |
Total 25(OH)D, ng/mL | −0.16** | −0.14** | 0.05 | −0.12* | −0.08 | −0.11* | −0.15** | −0.14** |
Dietary intake | ||||||||
Total fat, %TE | 0.02 | 0.01 | −0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
SFA %TE | 0.04 | 0.06 | 0.01 | 0.08 | 0.06 | 0.04 | 0.03 | 0.04 |
MUFA, %TE | 0.01 | −0.01 | −0.05 | −0.02 | −0.01 | −0.004 | 0.02 | −0.01 |
PUFA, %TE | −0.07 | −0.15** | −0.09 | −0.13* | −0.16** | −0.13* | −0.04 | −0.14** |
n-6 PUFA, %TE | −0.08 | −0.16** | −0.11* | −0.17** | −0.19** | −0.15** | −0.02 | −0.18** |
n-3 PUFA, %TE | −0.004 | −0.05 | −0.08 | 0.01 | −0.04 | −0.01 | 0.02 | −0.03 |
Trans fat, %TE | 0.07 | 0.11* | 0.07 | 0.16** | 0.13** | 0.11* | 0.04 | 0.12* |
Protein, %TE | −0.03 | −0.003 | 0.07 | −0.04 | −0.02 | −0.05 | −0.03 | −0.07 |
Carbohydrate, %TE | 0.02 | 0.003 | −0.05 | −0.03 | 0.001 | 0.02 | 0.03 | 0.01 |
Fibre (AOAC), g/day | −0.22** | −0.14** | 0.21** | −0.06 | −0.13* | −0.21** | −0.21** | −0.07 |
Total Sugars, %TE | 0.03 | −0.01 | −0.11* | −0.14** | −0.04 | −0.04 | 0.07 | −0.11* |
Data analysed by Spearman’s correlations
AOAC association of analytical chemists, A/G android to gynoid ratio, CRP C-reactive protein, GGT gamma-glutamyl transferase, HDL-C high density lipoprotein cholesterol, HOMA-IR homeostatic model assessment for insulin resistance, LDL-C low density lipoprotein cholesterol, MUFA monounsaturated fatty acids, NEFA non-esterified fatty acids, PUFA polyunsaturated fatty acids, SFA saturated fatty acids, TC total cholesterol, TAG triacylglycerol, %TE % of total energy, VAT abdominal visceral adipose tissue, total 25(OH)D: 25-hydroxyvitamin D
*Significant differences at the 0.05 level
**Significant differences at the 0.01 level